Skip to search formSkip to main contentSkip to account menu

Ophthalmic Solution

Known as: Ophthalmic Solution [Dose Form], Ophthalmic Solutions, Solutions, Ophthalmic 
A sterile solution containing a particular pharmaceutical agent administered to the external eye, usually in the form of droplets. An ophthalmic… 
National Institutes of Health

Related topics

Related topics

50 relations
Brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [Alphagan]Carboxymethylcellulose Sodium 5 MG/ML / Glycerin 9 MG/ML Ophthalmic SolutionCarboxymethylcellulose Sodium 5 MG/ML Ophthalmic SolutionCiprofloxacin 3 MG/ML Ophthalmic Solution
Expand

Broader (1)

OPHTHALMIC AGENTS

Narrower (2)

Water 991 MG/ML Ophthalmic Irrigation Solutionlifitegrast

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study
Purpose: To evaluate the 1-year safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease compared with… 
Highly Cited
2012
Highly Cited
2012
A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
Aims To compare the efficacy and safety of 3% diquafosol ophthalmic solution with those of 0.1% sodium hyaluronate ophthalmic… 
Highly Cited
2010
Highly Cited
2010
Multicenter Open-Label Study Evaluating the Efficacy of Azithromycin Ophthalmic Solution 1% on the Signs and Symptoms of Subjects With Blepharitis
Purpose: To evaluate the effect of 4 weeks of treatment with azithromycin ophthalmic solution 1% on eyelid bacterial load, tear… 
Highly Cited
2010
Highly Cited
2010
pH dependent spectral properties of sodium fluorescein ophthalmic solutions revisited
  • M. Doughty
  • Ophthalmic & physiological optics : the journal…
  • 2010
  • Corpus ID: 205636266
Purpose:  To re‐assess and further quantify the pH‐related changes in the absorbance and fluorescence emission spectra of sodium… 
Review
2008
Review
2008
Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
Moxifloxacin hydrochloride ophthalmic solution 0.5% (Vigamox®) is the ocular formulation/adaptation of moxifloxacin. Moxifloxacin… 
Highly Cited
2008
Highly Cited
2008
Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells
Purpose:  The cytotoxicity of a range of commercial ophthalmic solutions in the presence and absence of preservatives was… 
Highly Cited
2007
Highly Cited
2007
Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
Highly Cited
2004
Highly Cited
2004
Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin.
Highly Cited
1991
Highly Cited
1991
Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis.
  • H. Leibowitz
  • American journal of ophthalmology
  • 1991
  • Corpus ID: 26008783
A multicenter, prospective clinical study of 148 culture-proven cases of bacterial keratitis, treated with ciprofloxacin 0.3… 
Highly Cited
1976
Highly Cited
1976
Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.
Timolol ophthalmic solutions 0.5 per cent, 1.0 per cent, and 1.5 per cent lowered intraocular pressures significantly in normal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License